• NeuroRx Reports Phase 2 Efficacy for NRX-101 americanpharmaceuticalreview
    May 31, 2019
    NeuroRx announced statistically significant final results from its Phase 2 STABIL-B study of NRX-101 versus lurasidone in patients with Severe Bipolar Depression and Acute Suicidal Ideation or Behavior (ASIB).
PharmaSources Customer Service